Focus on increasing throughput of processes has favoured poorer models with lower chances of success
The search for new medicines is becoming unsustainably expensive despite huge technological advances because researchers are using the wrong methods, experts say.
They say drug discovery should focus on ‘validity’ – how well the results of experiments predict results in sick people. Instead, it has focused on methods that are easy to industrialize or methods that are academically fashionable.
In a report published in the journal PLOS ONE, Jack Scannell, from Oxford University’s Centre for the Advancement of Sustainable Medical Innovation, and consultant Jim Bosley approach drug discovery using mathematical tools that are used by economists to study decision making. They show that the chance of discovering an effective drug is surprisingly sensitive to the validity of the experimental methods. Small changes in validity can have a bigger effect than running 10 or even 100 times more experiments.
They argue that productivity has declined because the most predictive methods lead to the discovery of good drugs, and research in those areas stops (e.g., stomach ulcers). This leaves scientists working on as-yet-untreated diseases using less predictive discovery methods (e.g., Alzheimer’s). They also suggest that changing industrial and scientific fashions have contributed to the problem.
The result: Methods have become less predictive over time, worse decisions have been made, and the cost of discovery has gone up.
Drug approvals have increased since 2012. The researchers say that this is likely down to the rising use of genetic information which improves the validity of the methods to discover treatments for rare diseases, though less so for common diseases.
Dr Jack Scannell said: ‘There is a nasty puzzle at the heart of modern biomedical research. On one hand, the technologies that people think are important have become hundreds, thousands, or even billions of times cheaper. On the other hand, it costs nearly 100 times more to bring a drug to market today than it did in 1950. New drugs can be very expensive, yet the industry is closing labs and firing scientists. Our work goes some way towards explaining the puzzle. Governments, companies, and charities should focus on identifying and funding predictive methods, even if they don’t match current scientific fashion.’
The Latest on: Drug development crisis
via Google News
The Latest on: Drug development crisis
- How to Address the Opiod Crisis with Your Kids and Keep Them Safeon August 5, 2020 at 10:05 pm
The Opioid crisis touches many families. According to the CDC, more than 750,000 Americans died from overdoses between 1999 and 2018. It’s the leading cause of accidental death in the US. The chance ...
- Opioid Crisis: A perfect stormon August 5, 2020 at 6:30 am
We are living in unprecedented times. Anxiety about money, unemployment and fears of contracting or transmitting a potentially deadly disease plagues most of us. During normal times many of us ...
- Advocacy Group Urges Drug Company To Move Forward With Remdesivir Alternativeon August 4, 2020 at 9:57 am
Public Citizen claims that Gilead is looking to make a bigger profit on its GS-441524 drug to treat COVID-19, and has delayed development as a result.
- How COVID-19 has added to the problem of drug-resistant antibioticson July 30, 2020 at 4:00 pm
This lack of new antibiotics has allowed the kinds of drug-resistant bacteria that took Simon's life to evolve and multiply, mostly unchecked. Years of antibiotic overuse have exa ...
- Coronavirus crisis disrupts addiction treatmenton July 30, 2020 at 10:54 am
who oversees business development for the Salvation Army's rehab facilities in the Midwest. "When financially we struggle, that is then felt on the other side." For instance, the Salvation Army drug ...
- Commentary: How COVID-19 has added to the problem of drug-resistant antibioticson July 28, 2020 at 6:04 pm
As the world grapples with COVID-19, another pandemic has gone mostly unnoticed. Each year, 700,000 people - including as many as 160,000 Americans - lose their lives to antibiotic-resistant bacteria.
- Pfizer raises 2020 profit forecast on projected recovery in drug saleson July 28, 2020 at 7:02 am
(Reuters) – Pfizer Inc raised its full-year earnings forecast on Tuesday, as the U.S. drugmaker predicted a recovery in vaccination rates and visits to doctors after patients avoided hospitals ...
- Bringing drug manufacture back to America (and New York): Another Trump triumphon July 28, 2020 at 12:53 am
The US International Development Finance ... capability in times of crisis. America is dangerously dependent on foreign supply chains for all three stages of drug production: starting materials ...
- Trump visits North Carolina vaccine development site seeking political shot in the armon July 27, 2020 at 11:04 pm
Trump's Monday afternoon trip to Morrisville is his first public event in the state since the eve of the March 3 presidential primary.
- Trump signs executive orders aimed at lowering drug prices in largely symbolic moveon July 25, 2020 at 3:37 am
The orders are regarded as a political gesture because they are unlikely to take effect anytime soon, if they do so at all.
via Bing News